{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:01:38Z","timestamp":1784124098661,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12020-020-02268-7","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T14:03:02Z","timestamp":1585749782000},"page":"557-563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor"],"prefix":"10.1007","volume":"68","author":[{"given":"Roc\u00edo","family":"Aller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Sig\u00fcenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Pina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Laserna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Antol\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Burgue\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Dur\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olatz","family":"Izaola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Primo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Antonio","family":"de Luis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"2268_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.recesp.2013.09.031","volume":"67","author":"S Vald\u00e9s","year":"2014","unstructured":"S. Vald\u00e9s, F. Garc\u00eda-Torres, C. Maldonado-Araque, A. Goday, A. Calle-Pascual, F. Soriguer, L. Casta\u00f1o, M. Catal\u00e1, R. Gomis, G. Rojo-Mart\u00ednez, Di@bet.es study group prevalence of obesity, diabetes and other cardiovascular risk factors in Andalusia (southern Spain). Comparison with national prevalence data. The Di@bet.es study. Rev. Esp. Cardiol. 67, 442\u2013448 (2014)","journal-title":"Rev. Esp. Cardiol."},{"key":"2268_CR2","first-page":"101","volume":"4","author":"HB Bhatt","year":"2015","unstructured":"H.B. Bhatt, R.J. Smith, Fatty liver disease in diabetes mellitus. Hepatobiliary Surg. Nutr. 4, 101\u2013108 (2015)","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"2268_CR3","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","volume":"37","author":"G Marchesini","year":"2003","unstructured":"G. Marchesini, E. Bugianesi, G. Forlani et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917\u2013923 (2003)","journal-title":"Hepatology"},{"key":"2268_CR4","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/hep.25762","volume":"55","author":"N Chalasani","year":"2012","unstructured":"N. Chalasani, Z. Younossi, J.E. Lavine et al. The diagnosis and management of non alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005\u20132023 (2012)","journal-title":"Hepatology"},{"key":"2268_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"L.A. Adams, J.F. Lymp, J.S. Sauver et al. The natural history of non-alcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113\u2013121 (2005)","journal-title":"Gastroenterology"},{"key":"2268_CR6","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1097\/MEG.0b013e328355b87f","volume":"24","author":"L Caballer\u00eda","year":"2012","unstructured":"L. Caballer\u00eda, G. Pera, L. Rodr\u00edguez et al. Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used. Eur. J. Gastroenterol. Hepatol. 24, 1007\u20131011 (2012)","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"2268_CR7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1503\/cmaj.045232","volume":"172","author":"LA Adams","year":"2005","unstructured":"L.A. Adams, P. Angulo, K.D. Lindor, Nonalcoholic fatty liver disease. CMAJ 172, 899\u2013905 (2005)","journal-title":"CMAJ"},{"key":"2268_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MED.0b013e3283293015","volume":"16","author":"K Cusi","year":"2009","unstructured":"K. Cusi, Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr. Opin. Endocrinol. Diabetes Obes. 16, 141\u2013149 (2009)","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"2268_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/hep.23784","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"B.A. Neuschwander-Tetri, J.M. Clark, N.M. Bass et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 52, 913\u2013924 (2010)","journal-title":"Hepatology"},{"key":"2268_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"E. Vilar-Gomez, Y. Martinez-Perez, L. Calzadilla-Bertot, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149, 367\u2013378.e5 (2015)","journal-title":"Gastroenterology"},{"key":"2268_CR11","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/gut.2007.146019","volume":"57","author":"SA Harrison","year":"2008","unstructured":"S.A. Harrison, D. Oliver, H.L. Arnold et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 57, 1441\u20131447 (2008)","journal-title":"Gut"},{"key":"2268_CR12","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"P. Angulo, J.M. Hui, G. Marchesini et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45, 846\u2013854 (2007)","journal-title":"Hepatology"},{"key":"2268_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/hep.25772","volume":"56","author":"R Loomba","year":"2012","unstructured":"R. Loomba, M. Abraham, A. Unalp et al. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 56, 943\u2013951 (2012)","journal-title":"Hepatology"},{"key":"2268_CR14","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.4254\/wjh.v7.i25.2610","volume":"7","author":"BK Puchakayala","year":"2015","unstructured":"B.K. Puchakayala, S. Verma, P. Kanwar et al., Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease. World J. Hepatol. 7, 2610\u20132618 (2015)","journal-title":"World J. Hepatol."},{"issue":"Suppl 1","key":"2268_CR15","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association, Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 41 Suppl 1, S13\u2013S27 (2018)","journal-title":"Diabetes Care."},{"key":"2268_CR16","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA 285, 2486\u20132489 (2001)","DOI":"10.1001\/jama.285.19.2486"},{"key":"2268_CR17","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1093\/ajcn\/41.4.810","volume":"41","author":"H Lukaski","year":"1985","unstructured":"H. Lukaski, P.E. Johson, Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am. J. Clin. Nutr. 41, 810\u2013817 (1985)","journal-title":"Am. J. Clin. Nutr."},{"key":"2268_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043134","volume":"7","author":"MA Mart\u00ednez-Gonz\u00e1lez","year":"2012","unstructured":"M.A. Mart\u00ednez-Gonz\u00e1lez, A. Garc\u00eda-Arellano, Toledo et al. A 14-Item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: the PREDIMED trial. PLoS ONE 7, e43134 (2012)","journal-title":"PLoS ONE"},{"key":"2268_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"W.T. Friedewald, R.J. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18, 499\u2013502 (1972)","journal-title":"Clin. Chem."},{"key":"2268_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"D.R. Matthews, J.P. Hosker, A.S. Rudenski et al. Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985)","journal-title":"Diabetologia"},{"key":"2268_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/01.CIR.0000112379.88385.67","volume":"109","author":"SM Grundy","year":"2004","unstructured":"S.M. Grundy, B. Hansen, S.C. Smith, J.I. Cleeman, R.A. Kahn, Clinical management of metabolic syndrome report of the American Heart Association\/National Heart, Lung, and Blood Institute\/American Diabetes Association Conference on scientific issues related to management. Circulation 109, 551\u2013556 (2004)","journal-title":"Circulation"},{"issue":"Suppl 1","key":"2268_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/liv.13301","volume":"37","author":"P Bedossa","year":"2017","unstructured":"P. Bedossa, Pathology of non-alcoholic fatty liver disease. Liver Int. 37 Suppl 1, 85\u201389 (2017)","journal-title":"Liver Int."},{"key":"2268_CR23","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1440-1746.2004.03312.x","volume":"19","author":"P Gupte","year":"2004","unstructured":"P. Gupte, D. Amarapurkar, S. Agal, R. Baijal, P. Kulshrestha, S. Pramanik, N. Patel, A. Madan, A. Amarapurkar, Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J. Gastroenterol. Hepatol. 19, 854\u2013858 (2004)","journal-title":"J. Gastroenterol. Hepatol."},{"key":"2268_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1751-2980.2008.00323.x","volume":"9","author":"JG Fan","year":"2008","unstructured":"J.G. Fan, Impact of non-alcoholic fatty liver disease on accelerated metabolic complications. J. Dig. Dis. 9, 63\u201367 (2008)","journal-title":"J. Dig. Dis."},{"key":"2268_CR25","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jhep.2010.04.030","volume":"53","author":"G Targher","year":"2010","unstructured":"G. Targher, L. Bertolini, R. Padovani et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J. Hepatol. 53, 713\u2013718 (2010)","journal-title":"J. Hepatol."},{"key":"2268_CR26","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00125-010-1720-1","volume":"53","author":"G Targher","year":"2010","unstructured":"G. Targher, L. Bertolini, M. Chonchol et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients. Diabetologia 53, 1341\u20131348 (2010)","journal-title":"Diabetologia"},{"key":"2268_CR27","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.metabol.2015.09.017","volume":"65","author":"A Lonardo","year":"2016","unstructured":"A. Lonardo, S. Sookoian, C.J. Pirola et al. Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism 65, 1136\u20131150 (2016)","journal-title":"Metabolism"},{"key":"2268_CR28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"A.S. Lok, B.J. McMahon, Chronic hepatitis B: update 2009. Hepatology 50, 661\u2013662 (2009)","journal-title":"Hepatology"},{"key":"2268_CR29","volume":"30","author":"F Coccia","year":"2019","unstructured":"F. Coccia, M. Testa, G. Guarisco, C. Di Cristofano, G. Silecchia, F. Leonetti, A. Gastaldelli, D. Capoccia, Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD. Nutr. Metab. Cardiovasc. Dis. 30, pii: S0939-4753(19)30306-0 (2019)","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"2268_CR30","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/gut.2006.107946","volume":"56","author":"G Svegliati-Baroni","year":"2007","unstructured":"G. Svegliati-Baroni, E. Bugianesi, T. Bouserhal, F. Marini, F. Ridolfi, F. Tarsetti et al. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. Gut 56, 1296\u20131301 (2007)","journal-title":"Gut"},{"key":"2268_CR31","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.22429","volume":"48","author":"A Ludovica Fracanzani","year":"2008","unstructured":"A. Ludovica Fracanzani, L. Valenti, E. Bugianesi, M. Andreoletti, A. Colli, E. Vanni et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 48, 792\u2013798 (2008)","journal-title":"Hepatology"},{"key":"2268_CR32","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/hep.23593","volume":"51","author":"EK Speliotes","year":"2010","unstructured":"E.K. Speliotes, J.M. Massaro, U. Hoffmann, R.S. Vasan, J.B. Meigs, D.V. Sahani et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the framingham heart study. Hepatology 51, 1979\u20131987 (2010)","journal-title":"Hepatology"},{"key":"2268_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3350\/kjhep.2011.17.1.27","volume":"17","author":"HJ Oh","year":"2011","unstructured":"H.J. Oh, T.H. Kim, Y.W. Sohn et al. Association of serum alanine aminotransferase and gamma-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease. Korean J. Hepatol. 17, 27\u201336 (2011)","journal-title":"Korean J. Hepatol."},{"key":"2268_CR34","doi-asserted-by":"publisher","first-page":"16831","DOI":"10.3748\/wjg.v20.i45.16831","volume":"20","author":"L Abenavoli","year":"2014","unstructured":"L. Abenavoli, N. Milic, V. Peta et al. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet. World J. Gastroenterol. 20, 16831\u201316840 (2014)","journal-title":"World J. Gastroenterol."},{"key":"2268_CR35","first-page":"1","volume":"8","author":"K Rees","year":"2012","unstructured":"K. Rees, L. Hartley, N. Flowers, Mediterranean\u2019 dietary pattern for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 8, 1\u201314 (2012)","journal-title":"Cochrane Database Syst. Rev."},{"key":"2268_CR36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1089\/ars.2016.6776","volume":"26","author":"S Spahis","year":"2017","unstructured":"S. Spahis, E. Delvin, J.M. Borys et al. Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis. Antioxid. Redox Signal. 26, 519\u2013541 (2017)","journal-title":"Antioxid. Redox Signal."},{"key":"2268_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu11122878","volume":"11","author":"K Riazi","year":"2019","unstructured":"K. Riazi, M.I. Raman, L. Taylor, M.G. Swain, A.A. Shaheen, Dietary patterns and components in nonalcoholic fatty liver disease (NAFLD): what key messages can health care providers offer? Nutrients 11, 1\u201317 (2019)","journal-title":"Nutrients"},{"key":"2268_CR38","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00125-016-3930-7","volume":"59","author":"E Bugianesi","year":"2016","unstructured":"E. Bugianesi, EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action? Diabetologia 59, 1145\u20131147 (2016)","journal-title":"Diabetologia"},{"issue":"37","key":"2268_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012356","volume":"97","author":"H Zhao","year":"2018","unstructured":"H. Zhao, X. Song, Z. Li, X. Wang, Risk factors associated with non-alcohol fatty liver disease and fibrosis among patients with type 2 diabetes mellitus. Medicine 97(37), e12356 (2018)","journal-title":"Medicine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02268-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-020-02268-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02268-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T23:44:48Z","timestamp":1617234288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-020-02268-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2268"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02268-7","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]},"assertion":[{"value":"13 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee (HVUVA committee 4\/2018) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}